Microbiome
The Impact of Caesarean Section on the Risk of Childhood Overweight and Obesity: New Evidence from a Contemporary Cohort Study
- G. Masukume; S. M. O'Neill; P. N. Baker; L. C. Kenny; S. M. B. Morton; A. S. Khashan The Impact of Caesarean Section on the Risk of Childhood Overweight and Obesity: New Evidence from a Contemporary Cohort Study Sci Rep
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
-
J. A. Elliott; J. V. Reynolds
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol
Dietary Studies GORD Insulin resistance & diabetes Medications Metabolic Syndrome Microbiome Physical Activity/Exercise Surgical Procedures
Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery
- Q. Wu; J. V. Li; F. Seyfried; C. W. le Roux; H. Ashrafian; T. Athanasiou; W. Fenske; A. Darzi; J. K. Nicholson; E. Holmes; N. J. Gooderham Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery Int J Obes (Lond)
Urinary phenotyping indicates weight loss-independent metabolic effects of roux-en-Y gastric bypass in mice
- F. Seyfried; J. V. Li; A. D. Miras; N. L. Cluny; M. Lannoo; W. K. Fenske; K. A. Sharkey; J. K. Nicholson; C. W. Le Roux; E. Holmes Urinary phenotyping indicates weight loss-independent metabolic effects of roux-en-Y gastric bypass in mice Journal of Proteome Research
Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile
- K. J. Neff; P. K. O'Donohoe; C. W. le Roux Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile Expert Rev Endocrinol Metab
The role of bariatric surgery to treat diabetes: current challenges and perspectives
- C. Koliaki; S. Liatis; C. W. le Roux; A. Kokkinos The role of bariatric surgery to treat diabetes: current challenges and perspectives BMC Endocr Disord
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
- M. A. Glaysher; A. Mohanaruban; C. G. Prechtl; A. P. Goldstone; A. D. Miras; J. Lord; N. Chhina; E. Falaschetti; N. A. Johnson; W. Al-Najim; C. Smith; J. V. Li; M. Patel; A. R. Ahmed; M. Moore; N. Poulter; S. Bloom; A. Darzi; C. Le Roux; J. P. Byrne; J. P A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus BMJ Open
Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy
- N. G. Docherty; C. W. Le Roux Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy Current Opinion in Pharmacology